4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005230
CHIEF FINANCIAL OFFICER gave up 890 shares (to pay taxes)
- CHIEF FINANCIAL OFFICER acquired 3,030 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-03-16 | Option exercise | +872 | 8,543 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-03-16 | Shares withheld for taxes | −256 | $11.46 | $2,934 | 8,287 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-03-20 | Option exercise | +2,158 | 10,445 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-03-20 | Shares withheld for taxes | −634 | $11.12 | $7,050 | 9,811 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-03-16 | Option exercise · Restricted Share Unit | −872 | 1,744 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-03-20 | Option exercise · Restricted Share Unit | −2,158 | 0 | D | ||
Loading xslF345X04/form4-03202023_090333.xml…